Team | Year | Age | GS | G | IP | W | L | SV | BS | K | BB | H | HR | K% | BB% | HR% | LOB% | GB% | WHIP | BABIP | ERA | FIP | FIP- | xFIP | E-F | WAR |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Frederick - WCL (AA)
FRD - WCL (AA)
|
2059 | 23 | 3 | 3 | 22.1 | 2 | 0 | 0 | 0 | 19 | 2 | 23 | 0 | 20.9% | 2.20% | 0.0% | 80.8% | 47.7% | 1.12 | .333 | 1.21 | 2.10 | 50 | 3.30 | -0.89 | 0.96 |
Frederick - WCL (AA)
FRD - WCL (AA)
|
2058 | 22 | 8 | 8 | 50.2 | 4 | 1 | 0 | 0 | 46 | 11 | 47 | 2 | 21.7% | 5.19% | 0.9% | 70.4% | 61.2% | 1.14 | .306 | 3.02 | 2.92 | 72 | 3.47 | 0.10 | 1.47 |
Frederick - WCL (AA)
FRD - WCL (AA)
|
2057 | 21 | 24 | 24 | 159.0 | 12 | 4 | 0 | 0 | 127 | 46 | 177 | 16 | 18.2% | 6.61% | 2.3% | 75.6% | 63.4% | 1.40 | .330 | 3.79 | 4.13 | 99 | 3.90 | -0.33 | 2.12 |
Frederick - WCL (AA)
FRD - WCL (AA)
|
2056 | 20 | 13 | 13 | 75.2 | 6 | 4 | 0 | 0 | 60 | 30 | 84 | 6 | 17.7% | 8.85% | 1.8% | 72.1% | 60.9% | 1.51 | .335 | 3.69 | 4.29 | 100 | 4.40 | -0.61 | 0.99 |
Cayman - DRAKE
CAY - DRAKE
|
2055 | 19 | 7 | 7 | 31.2 | 3 | 2 | 0 | 0 | 26 | 8 | 43 | 4 | 18.7% | 5.76% | 2.9% | 68.3% | 65.6% | 1.61 | .398 | 5.40 | 5.06 | 98 | 4.27 | 0.34 | 0.48 |
Assateague - SNL (R)
ASS - SNL (R)
|
2054 | 18 | 11 | 11 | 69.2 | 5 | 3 | 0 | 0 | 66 | 15 | 68 | 9 | 23.0% | 5.23% | 3.1% | 69.1% | 62.6% | 1.19 | .304 | 4.00 | 4.17 | 91 | 3.73 | -0.17 | 1.35 |
Kingston - SNL (R)
KNG - SNL (R)
|
2053 | 17 | 8 | 8 | 37.2 | 1 | 0 | 0 | 0 | 42 | 3 | 31 | 1 | 28.8% | 2.05% | 0.7% | 77.4% | 58.2% | 0.90 | .303 | 1.91 | 1.89 | 49 | 2.52 | 0.02 | 1.59 |
Kingston - SNL (R)
KNG - SNL (R)
|
2052 | 16 | 13 | 13 | 62.1 | 3 | 7 | 0 | 0 | 51 | 16 | 74 | 10 | 18.7% | 5.86% | 3.7% | 72.2% | 61.1% | 1.44 | .332 | 4.76 | 4.77 | 111 | 3.97 | -0.00 | 0.67 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2052 | 16 | 9 | 9 | 40.1 | 3 | 1 | 0 | 0 | 43 | 21 | 48 | 3 | 23.2% | 11.35% | 1.6% | 75.2% | 64.3% | 1.71 | .395 | 4.46 | 3.80 | 77 | 4.56 | 0.67 | 1.14 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2051 | 15 | 9 | 9 | 51.1 | 5 | 2 | 0 | 0 | 46 | 15 | 38 | 4 | 22.4% | 7.32% | 2.0% | 71.7% | 56.3% | 1.03 | .245 | 2.10 | 3.31 | 67 | 5.03 | -1.21 | 1.91 |
Pfizer - HSAS (HS)
PFZ - HSAS (HS)
|
2050 | 14 | 9 | 9 | 48.0 | 3 | 3 | 0 | 0 | 50 | 14 | 29 | 2 | 27.5% | 7.69% | 1.1% | 82.5% | 56.8% | 0.90 | .237 | 1.88 | 2.16 | 50 | 3.83 | -0.29 | 2.13 |
Total - AA
AA
|
48 | 48 | 307.2 | 24 | 9 | 0 | 0 | 252 | 89 | 331 | 24 | 18.8% | 6.65% | 1.8% | 74.2% | 61.3% | 1.37 | .328 | 3.45 | 3.82 | 91 | 3.91 | -0.37 | 5.54 | ||
Total - S A
S A
|
7 | 7 | 31.2 | 3 | 2 | 0 | 0 | 26 | 8 | 43 | 4 | 18.7% | 5.76% | 2.9% | 68.3% | 65.6% | 1.61 | .398 | 5.40 | 5.06 | 98 | 4.27 | 0.34 | 0.48 | ||
Total - R
R
|
32 | 32 | 169.2 | 9 | 10 | 0 | 0 | 159 | 34 | 173 | 20 | 22.5% | 4.82% | 2.8% | 71.9% | 61.1% | 1.22 | .315 | 3.82 | 3.89 | 89 | 3.55 | -0.07 | 3.61 | ||
Total - HS
HS
|
27 | 27 | 139.2 | 11 | 6 | 0 | 0 | 139 | 50 | 115 | 9 | 24.3% | 8.74% | 1.6% | 76.1% | 58.6% | 1.18 | .289 | 2.71 | 3.06 | 64 | 4.48 | -0.35 | 5.18 | ||
Total - Minors
Minors
|
87 | 87 | 509.0 | 36 | 21 | 0 | 0 | 437 | 131 | 547 | 48 | 20.0% | 6.00% | 2.2% | 73.1% | 61.5% | 1.33 | .328 | 3.70 | 3.92 | 91 | 3.81 | -0.22 | 9.63 |